These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 33071049)

  • 1. Comparison of the eighth edition of the TNM and Brigham Women's Hospital staging systems for cutaneous squamous cell carcinoma of the head and neck: a six-year review.
    Bowe CM; Houlton S; Walsh S
    Br J Oral Maxillofac Surg; 2020 Nov; 58(9):1158-1163. PubMed ID: 33071049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the American Joint Committee on Cancer Seventh Edition and Brigham and Women's Hospital Cutaneous Squamous Cell Carcinoma Tumor Staging in Immunosuppressed Patients.
    Gonzalez JL; Cunningham K; Silverman R; Madan E; Nguyen BM
    Dermatol Surg; 2017 Jun; 43(6):784-791. PubMed ID: 28079640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stratification of Poor Outcomes for Cutaneous Squamous Cell Carcinoma in Immunosuppressed Patients Using the American Joint Committee on Cancer Eighth Edition and Brigham and Women's Hospital Staging Systems.
    Blechman AB; Carucci JA; Stevenson ML
    Dermatol Surg; 2019 Sep; 45(9):1117-1124. PubMed ID: 30640779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparing the eighth and the seventh editions of the American Joint Committee on Cancer staging system and the Brigham and Women's Hospital alternative staging system for cutaneous squamous cell carcinoma: Implications for clinical practice.
    Cañueto J; Burguillo J; Moyano-Bueno D; Viñolas-Cuadros A; Conde-Ferreirós A; Corchete-Sánchez LA; Pérez-Losada J; Román-Curto C
    J Am Acad Dermatol; 2019 Jan; 80(1):106-113.e2. PubMed ID: 30003984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of American Joint Committee on Cancer, International Union Against Cancer, and Brigham and Women's Hospital tumor staging for cutaneous squamous cell carcinoma.
    Karia PS; Jambusaria-Pahlajani A; Harrington DP; Murphy GF; Qureshi AA; Schmults CD
    J Clin Oncol; 2014 Feb; 32(4):327-34. PubMed ID: 24366933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term clinical outcomes of patients with invasive cutaneous squamous cell carcinoma treated with Mohs micrographic surgery: A 5-year, multicenter, prospective cohort study.
    Tschetter AJ; Campoli MR; Zitelli JA; Brodland DG
    J Am Acad Dermatol; 2020 Jan; 82(1):139-148. PubMed ID: 31279037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of selected risk factors for nodal metastases in head and neck cutaneous squamous cell carcinoma.
    Szewczyk M; Pazdrowski J; Golusiński P; Dańczak-Pazdrowska A; Marszałek S; Golusiński W
    Eur Arch Otorhinolaryngol; 2015 Oct; 272(10):3007-12. PubMed ID: 25217080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validating 4 Staging Systems for Cutaneous Squamous Cell Carcinoma Using Population-Based Data: A Nested Case-Control Study.
    Roscher I; Falk RS; Vos L; Clausen OPF; Helsing P; Gjersvik P; Robsahm TE
    JAMA Dermatol; 2018 Apr; 154(4):428-434. PubMed ID: 29516080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the eighth edition of the TNM and Brigham Women's Hospital staging systems for cutaneous squamous cell carcinoma of the head and neck: a six-year review.
    Bowe CM; Walsh S
    Br J Oral Maxillofac Surg; 2021 Dec; 59(10):1322-1323. PubMed ID: 34266702
    [No Abstract]   [Full Text] [Related]  

  • 10. Prognostic Value of Tumor Staging: Predicting Nodal Metastases in Cutaneous Squamous Cell Carcinoma.
    Upton M; Kita A; Scapa J; St John M
    Laryngoscope; 2021 Jan; 131(1):E170-E175. PubMed ID: 32212346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of the UICC 8th edition staging of oral cavity squamous cell carcinoma in a UK cohort.
    McGoldrick DM; Torres-Rendon A; Sandhu R; Walton G
    Br J Oral Maxillofac Surg; 2021 Jan; 59(1):76-81. PubMed ID: 33082012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Re: Comparison of the eighth edition of the TNM and Brigham Women's Hospital staging systems for cutaneous squamous cell carcinoma of the head and neck: a six-year review.
    Chang C; Munro SP; Kyle D
    Br J Oral Maxillofac Surg; 2021 Dec; 59(10):1320-1321. PubMed ID: 34304918
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparison of tumor staging systems for cutaneous squamous cell carcinoma in patients with chronic lymphocytic leukemia.
    Inda JJ; Kabat BF; Larson MC; Slager SL; Baum CL
    J Am Acad Dermatol; 2019 Mar; 80(3):639-645. PubMed ID: 30165169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Performance of the American Joint Committee on Cancer Staging Manual, 8th Edition vs the Brigham and Women's Hospital Tumor Classification System for Cutaneous Squamous Cell Carcinoma.
    Ruiz ES; Karia PS; Besaw R; Schmults CD
    JAMA Dermatol; 2019 Jul; 155(7):819-825. PubMed ID: 30969315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical outcomes of high-risk cutaneous squamous cell carcinomas treated with Mohs surgery alone: An analysis of local recurrence, regional nodal metastases, progression-free survival, and disease-specific death.
    Soleymani T; Brodland DG; Arzeno J; Sharon DJ; Zitelli JA
    J Am Acad Dermatol; 2023 Jan; 88(1):109-117. PubMed ID: 35760236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. European interdisciplinary guideline on invasive squamous cell carcinoma of the skin: Part 1. epidemiology, diagnostics and prevention.
    Stratigos AJ; Garbe C; Dessinioti C; Lebbe C; Bataille V; Bastholt L; Dreno B; Fargnoli MC; Forsea AM; Frenard C; Harwood CΑ; Hauschild A; Hoeller C; Kandolf-Sekulovic L; Kaufmann R; Kelleners-Smeets NW; Malvehy J; Del Marmol V; Middleton MR; Moreno-Ramirez D; Pellecani G; Peris K; Saiag P; van den Beuken-van Everdingen MHJ; Vieira R; Zalaudek I; Eggermont AMM; Grob JJ;
    Eur J Cancer; 2020 Mar; 128():60-82. PubMed ID: 32113941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes of Patients With Multiple Cutaneous Squamous Cell Carcinomas: A 10-Year Single-Institution Cohort Study.
    Levine DE; Karia PS; Schmults CD
    JAMA Dermatol; 2015 Nov; 151(11):1220-5. PubMed ID: 26177278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brigham and Women's Hospital tumor classification system for basal cell carcinoma identifies patients with risk of metastasis and death.
    Morgan FC; Ruiz ES; Karia PS; Besaw RJ; Neel VA; Schmults CD
    J Am Acad Dermatol; 2021 Sep; 85(3):582-587. PubMed ID: 33497751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors Associated with Recurrence and Regional Adenopathy for Head and Neck Cutaneous Squamous Cell Carcinoma.
    Harris BN; Bayoumi A; Rao S; Moore MG; Farwell DG; Bewley AF
    Otolaryngol Head Neck Surg; 2017 May; 156(5):863-869. PubMed ID: 28322123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Artificial intelligence-empowered cellular morphometric risk score improves prognostic stratification of cutaneous squamous cell carcinoma.
    Pérez-Baena MJ; Mao JH; Pérez-Losada J; Santos-Briz Á; Chang H; Cañueto J
    Clin Exp Dermatol; 2024 Jun; 49(7):692-698. PubMed ID: 37572359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.